Navigation Links
Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
Date:7/17/2008

ely 680 patients. To be eligible, patients must have a viral load greater than 5,000 copies/mL at screening and may not have taken any anti-HIV drugs prior to enrolling, as well as meet other screening criteria. The primary endpoint of the studies is to assess the proportion of patients with viral load < 50 copies/mL at week 48 on TMC278 vs. control (EFV). The studies will last for 104 weeks, which includes a four-week screening period, a 96-week treatment period and a four-week follow-up period.

Results from both of these studies will be submitted to the U.S. Food and Drug Administration (FDA) for consideration for approval of TMC278.

TMC278 is the third anti-HIV compound to be developed by Tibotec Pharmaceuticals. Tibotec Pharmaceuticals is also developing other investigational compounds for the treatment of hepatitis C and tuberculosis.

For additional information on inclusion and exclusion criteria for both of these studies, please see http://www.clinicaltrials.gov or email info@tibbe.jnj.com.

About Tibotec Pharmaceuticals Ltd.

Tibotec Pharmaceuticals Ltd., based in Cork, Ireland, is a pharmaceutical research and development company. The Company's main research and development facilities are in Mechelen, Belgium with offices in Yardley, PA. Tibotec is dedicated to the discovery and development of innovative HIV/AIDS drugs and anti-infectives for diseases of high unmet medical need.

Tibotec is a member of the Johnson & Johnson family of companies.

Forward Looking Statement

This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from Tibotec's expectations and projections. Risks and uncertaint
'/>"/>

SOURCE Tibotec Pharmaceuticals Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AHF Criticizes Tibotec Over Steep Price for Newest AIDS Drug, Etravirine
2. Maine Natural Health Company Conducts Dental Clinical Trial
3. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
4. Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles
5. Terumo Heart Obtains IRB Approval from the University of Michigan to Initiate DuraHeart(TM) Left Ventricular Assist System U.S. Pivotal Trial
6. Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
7. Victory Pharma, Inc. Reports MGX006 Enters Into Pivotal Development Program
8. European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals
9. Medivation Initiates Second Pivotal Phase 3 Trial of Dimebon(TM) in Patients With Alzheimers Disease
10. Nephros Completes Pivotal U.S. Clinical Trial for its Hemodiafiltration Products
11. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , July 31, 2014  Cannabis Science, ... cannabis formulation-based drug development and related consulting, is ... of multiple strains of cannabis and European Union ... select the best strains for development of proprietary ... cannabis formulations to market for critical ailments such ...
(Date:7/31/2014)... , July 31, 2014 For the first ... watch the implantation of the SynCardia temporary Total Artificial ... matching video posted on the Journal of Visualized Experiments ... read the paper on the SynCardia Total Artificial Heart ... video accompanies "Implantation of the SynCardia Total Artificial Heart," ...
(Date:7/31/2014)... 2014 TB Alliance, a not-for-profit with ... and affordable treatments, announced the appointment of ... Affairs. Mr. Brock comes to TB Alliance having ... Relations for WWF International (formerly known as the ... will guide the TB Alliance,s resource development, advocacy ...
Breaking Medicine Technology:Cannabis Science Initiates Scientific Cultivation Programs to Test Multiple Strains of Cannabis to Obtain Extract Formulations for Clinical Drug Development Targeting Multiple Critical Ailments Starting with Cancer and Neurological Disorders 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 3TB Alliance Appoints Willo Brock Senior Vice President, External Affairs 2
... post-surgery hormone therapy reduced risk of breast cancer return ... First Phase III data to substantiate anticancer effect of ... prevention of bone complications due to bone metastases, with ... Feb. 11 /PRNewswire/ -- A newly published ...
... test to help guide treatment decisionsANN ARBOR, Mich., Feb. ... Comprehensive Cancer Center have identified a panel of ... prostate cancer.The finding could lead to a simple test ... slow-growing and which require immediate, aggressive treatment.Results of the ...
Cached Medicine Technology:Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports 2Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports 3Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports 4Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports 5Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports 6Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports 7Researchers Discover Metabolite Linked to Aggressive Prostate Cancer 2Researchers Discover Metabolite Linked to Aggressive Prostate Cancer 3
(Date:7/31/2014)... -- A class of medications previously linked to ... negatively affect their physical functioning according to investigators ... Center for Aging Research, the University of East ... In a systemic review of more than a ... with anticholinergic properties, they report that these drugs ...
(Date:7/31/2014)... application of vacuum pressure is a promising approach to ... an experimental study in the August issue of ... Congress of Neurological Surgeons . The journal is published ... of Wolters Kluwer Health . , "Mechanical ... area of the brainshows promise as a safe and ...
(Date:7/31/2014)... Las Vegas, Nevada (PRWEB) July 31, 2014 ... to provide next generation authentication services to cloud service ... way to utilize hardware protected multi-factor authentication with online ... the Internet's reliance on password-based authentication. It is the ... data breaches taking place around the globe. Instead of ...
(Date:7/31/2014)... 31, 2014 The Beryl Institute announces ... Board and four new members of its ... as the global community of practice and premier thought ... , Executive board members are industry leaders who advise ... valuable insight into market and industry trends. The advisory ...
(Date:7/31/2014)... Web Programming Services, a business partner of ... firm, has recently launched a new service named as ... for everyone, the company has announced a very nominal ... Programming Services has tailored the service after doing a ... likely expectations of the clients from their designers. This ...
Breaking Medicine News(10 mins):Health News:Common drugs adversely impair older adults' physical as well as cognitive functioning 2Health News:Vacuum treatment may limit damage after traumatic brain injury 2Health News:Rivetz Partners with LaunchKey to Offer Next Generation Authentication for Accounts Leveraging Trusted Execution Technology. 2Health News:Rivetz Partners with LaunchKey to Offer Next Generation Authentication for Accounts Leveraging Trusted Execution Technology. 3Health News:The Beryl Institute Announces Seven New Patient Experience Board Members 2Health News:The Beryl Institute Announces Seven New Patient Experience Board Members 3Health News:Web Programming Services Introduces Affordable Brochure Designing Service 2
... INDIANAPOLIS, Feb. 18 The Board of Directors of Eli ... Ralph Alvarez as a new member, effective April 1, 2009. ... of McDonald,s Corporation and is also a member of McDonald,s ... will serve on both the board,s finance committee and public ...
... Fla., Feb. 18 On March 2, 2009 at ... Florida will become Herzing University at a sign-changing event ... T-shirts and donating the profits to the American Cancer ... Heather Antonacci.This event represents the 44-year evolution of a ...
... R.I., Feb. 18 CVS Caremark Corporation (NYSE: ... into an agreement with the U.S. Federal Trade Commission ... Services Office for Civil Rights (OCR) concerning disposal of ... agreement resolves an investigation prompted by media reports from ...
... HOUSTON (Feb. 18, 2009) The fight ... will soon receive a boost from an ultrasound ... technology under development will allow early prediction of ... of fracture healing. , National Space Biomedical Research ...
... MeasuresWASHINGTON, Feb. 18 Patients across the United ... technology (HIT) law providing comprehensive privacy and security ... for psychotherapy records. The Health Information Technology for ... the economic stimulus package, was passed by the ...
... eligibility serviceFORT WORTH, Texas, Feb. 18 eRx ... services to the retail pharmacy industry, has announced ... solution, eRx CardFinder. The exclusive service, which was ... than 14,000 pharmacies nationwide."We place high significance on ...
Cached Medicine News:Health News:Ralph Alvarez Elected to Lilly Board of Directors 2Health News:Herzing College, Orlando Will Change Name to Herzing University and Host Sign-Changing Event on March 2, 2009 2Health News:Herzing College, Orlando Will Change Name to Herzing University and Host Sign-Changing Event on March 2, 2009 3Health News:CVS Caremark Issues Statement on Settlement Concerning Disposal of Patient Information at its Retail Stores 2Health News:SCAN: Delivering bone disorder diagnosis, fracture healing 2Health News:SCAN: Delivering bone disorder diagnosis, fracture healing 3Health News:Patients Gain Protections in Health Information Technology Law 2Health News:Patients Gain Protections in Health Information Technology Law 3Health News:eRx Network(R) Expands eRx CardFinder(TM) Reach 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: